Liver transplant for congenital factor VII deficiency

Melissa A. Acquazzino, Eric T. Rush, Ruben Quiros, Jill C Beck

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Congenital factor VII (FVII) deficiency is a rare, autosomal recessive bleeding disorder with a spectrum of phenotypes ranging from asymptomatic to life-threatening intra-cranial hemorrhage (ICH). Orthotopic liver transplantation has been described for definitive treatment in a few patients with severe manifestations. We report a patient with congenital FVII deficiency and recurrent ICH, despite twice-weekly prophylaxis with recombinant activated FVII. At 17 months of age, he underwent an orthotopic liver transplant. He is now 1-year post-transplant, on maintenance immunosuppression with no hemorrhage or other complications.

Original languageEnglish (US)
Pages (from-to)1886-1887
Number of pages2
JournalPediatric Blood and Cancer
Volume61
Issue number10
DOIs
StatePublished - Oct 2014

Fingerprint

Factor VII Deficiency
Hemorrhage
Transplants
Liver
Factor VIIa
Liver Transplantation
Immunosuppression
Maintenance
Phenotype

Keywords

  • Factor VII deficiency
  • Liver transplant

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Cite this

Liver transplant for congenital factor VII deficiency. / Acquazzino, Melissa A.; Rush, Eric T.; Quiros, Ruben; Beck, Jill C.

In: Pediatric Blood and Cancer, Vol. 61, No. 10, 10.2014, p. 1886-1887.

Research output: Contribution to journalArticle

Acquazzino, Melissa A. ; Rush, Eric T. ; Quiros, Ruben ; Beck, Jill C. / Liver transplant for congenital factor VII deficiency. In: Pediatric Blood and Cancer. 2014 ; Vol. 61, No. 10. pp. 1886-1887.
@article{3733311dcabd40e7be2790e141f791c5,
title = "Liver transplant for congenital factor VII deficiency",
abstract = "Congenital factor VII (FVII) deficiency is a rare, autosomal recessive bleeding disorder with a spectrum of phenotypes ranging from asymptomatic to life-threatening intra-cranial hemorrhage (ICH). Orthotopic liver transplantation has been described for definitive treatment in a few patients with severe manifestations. We report a patient with congenital FVII deficiency and recurrent ICH, despite twice-weekly prophylaxis with recombinant activated FVII. At 17 months of age, he underwent an orthotopic liver transplant. He is now 1-year post-transplant, on maintenance immunosuppression with no hemorrhage or other complications.",
keywords = "Factor VII deficiency, Liver transplant",
author = "Acquazzino, {Melissa A.} and Rush, {Eric T.} and Ruben Quiros and Beck, {Jill C}",
year = "2014",
month = "10",
doi = "10.1002/pbc.25008",
language = "English (US)",
volume = "61",
pages = "1886--1887",
journal = "Pediatric Blood and Cancer",
issn = "1545-5009",
publisher = "Wiley-Liss Inc.",
number = "10",

}

TY - JOUR

T1 - Liver transplant for congenital factor VII deficiency

AU - Acquazzino, Melissa A.

AU - Rush, Eric T.

AU - Quiros, Ruben

AU - Beck, Jill C

PY - 2014/10

Y1 - 2014/10

N2 - Congenital factor VII (FVII) deficiency is a rare, autosomal recessive bleeding disorder with a spectrum of phenotypes ranging from asymptomatic to life-threatening intra-cranial hemorrhage (ICH). Orthotopic liver transplantation has been described for definitive treatment in a few patients with severe manifestations. We report a patient with congenital FVII deficiency and recurrent ICH, despite twice-weekly prophylaxis with recombinant activated FVII. At 17 months of age, he underwent an orthotopic liver transplant. He is now 1-year post-transplant, on maintenance immunosuppression with no hemorrhage or other complications.

AB - Congenital factor VII (FVII) deficiency is a rare, autosomal recessive bleeding disorder with a spectrum of phenotypes ranging from asymptomatic to life-threatening intra-cranial hemorrhage (ICH). Orthotopic liver transplantation has been described for definitive treatment in a few patients with severe manifestations. We report a patient with congenital FVII deficiency and recurrent ICH, despite twice-weekly prophylaxis with recombinant activated FVII. At 17 months of age, he underwent an orthotopic liver transplant. He is now 1-year post-transplant, on maintenance immunosuppression with no hemorrhage or other complications.

KW - Factor VII deficiency

KW - Liver transplant

UR - http://www.scopus.com/inward/record.url?scp=84908530448&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908530448&partnerID=8YFLogxK

U2 - 10.1002/pbc.25008

DO - 10.1002/pbc.25008

M3 - Article

C2 - 24585521

AN - SCOPUS:84908530448

VL - 61

SP - 1886

EP - 1887

JO - Pediatric Blood and Cancer

JF - Pediatric Blood and Cancer

SN - 1545-5009

IS - 10

ER -